Skip to content

Drug interactions

Atazanavir + Ruxolitinib

Severity: Major

Atazanavir and Ruxolitinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atazanavir is a strong CYP3A4 inhibitor that increases ruxolitinib exposure, raising the risk of cytopenias and infection. Ruxolitinib labeling recommends dose reduction with strong CYP3A4 inhibitors.

What this interaction means in plain words

Atazanavir and Ruxolitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Atazanavir belongs to Anti Virals; Ruxolitinib belongs to Oncology.

Evidence level: High

Why it happens

CYP3A4 inhibition by atazanavir reduces ruxolitinib clearance.

What to do

Reduce the ruxolitinib dose per labeling for the indication and platelet count. Monitor blood counts frequently and adjust the dose accordingly.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atazanavir and Ruxolitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Atazanavir with Ruxolitinib?

MediHelp rates the interaction as major. Atazanavir and Ruxolitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Atazanavir is a strong CYP3A4 inhibitor that increases ruxolitinib exposure, raising the risk of cytopenias and infection. Ruxolitinib labeling recommends dose reduction with strong CYP3A4 inhibitors.

How serious is the interaction between Atazanavir and Ruxolitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the ruxolitinib dose per labeling for the indication and platelet count. Monitor blood counts frequently and adjust the dose accordingly.

What other medicines interact with Ruxolitinib?

MediHelp also lists interactions of Ruxolitinib with, for example, Ceritinib, Chloramphenicol, Cobicistat. The full list is on the Ruxolitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in